Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP‐C

Cerebellar ataxia is an exclusion criterion for the clinical diagnosis of progressive supranuclear palsy, but a variant with predominant cerebellar ataxia has been reported. The aims of this study were to estimate the frequency of progressive supranuclear palsy with predominant cerebellar ataxia in an autopsy series from the United States and to compare clinical, pathologic, and genetic differences between progressive supranuclear palsy with and without predominant cerebellar ataxia.

[1]  D. Dickson,et al.  Adult‐onset cerebello‐brainstem dominant form of X‐linked adrenoleukodystrophy presenting as multiple system atrophy: case report and literature review , 2016, Neuropathology : official journal of the Japanese Society of Neuropathology.

[2]  D. Dickson,et al.  When DLB, PD, and PSP masquerade as MSA , 2015, Neurology.

[3]  J. Olsen,et al.  Impact of Parkinson's disease risk loci on age at onset , 2015, Movement disorders : official journal of the Movement Disorder Society.

[4]  Keith A. Josephs,et al.  Key emerging issues in progressive supranuclear palsy and corticobasal degeneration , 2015, Journal of Neurology.

[5]  A. Lang.  Clinical heterogeneity in Progressive Supranuclear Palsy: Challenges to diagnosis, pathogenesis and future therapies , 2014, Movement disorders : official journal of the Movement Disorder Society.

[6]  E. Tolosa,et al.  The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases , 2014, Movement disorders : official journal of the Movement Disorder Society.

[7]  M. Murray,et al.  Differential clinicopathologic and genetic features of late-onset amnestic dementias , 2014, Acta Neuropathologica.

[8]  J. Olszewski,et al.  Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia , 2014, Seminars in Neurology.

[9]  H. Shill,et al.  Essential tremor is not associated with cerebellar Purkinje cell loss , 2014, Movement disorders : official journal of the Movement Disorder Society.

[10]  K. Hayashi,et al.  Cerebellar Expression of Copper Chaperone for Superoxide, Cytosolic Cu/Zn-Superoxide Dismutase, 4-Hydroxy-2-Nonenal, Acrolein and Heat Shock Protein 32 in Patients with Menkes Kinky Hair Disease: Immunohistochemical Study , 2014, Yonago acta medica.

[11]  Hitoshi Takahashi,et al.  Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia. , 2013, Parkinsonism & related disorders.

[12]  Mari Yoshida,et al.  An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement , 2013, Neuropathology : official journal of the Japanese Society of Neuropathology.

[13]  M. Farrer,et al.  An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[14]  R. Laureno.  Nutritional cerebellar degeneration, with comments on its relationship to Wernicke disease and alcoholism. , 2012, Handbook of clinical neurology.

[15]  Charles Duyckaerts,et al.  National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.

[16]  J. Pedroso,et al.  Progressive supranuclear palsy: new concepts. , 2010, Arquivos de neuro-psiquiatria.

[17]  D. Dickson,et al.  Neuropathology of variants of progressive supranuclear palsy. , 2010, Current opinion in neurology.

[18]  A. Kakita,et al.  The phenotype spectrum of Japanese multiple system atrophy , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  K. Jellinger.  Cerebellar involvement in progressive supranuclear palsy. , 2010, Movement disorders : official journal of the Movement Disorder Society.

[20]  M. Mimura,et al.  Clinical heterogeneity in progressive supranuclear palsy: Problems of clinical diagnostic criteria of NINDS‐SPSP in a retrospective study of seven Japanese autopsy cases , 2010, Neuropathology : official journal of the Japanese Society of Neuropathology.

[21]  A. Kakita,et al.  Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study , 2009, Movement disorders : official journal of the Movement Disorder Society.

[22]  David R Williams,et al.  Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges , 2009, The Lancet Neurology.

[23]  P Sandroni,et al.  Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.

[24]  D. Dickson,et al.  Co-localization of tau and α-synuclein in the olfactory bulb in Alzheimer’s disease with amygdala Lewy bodies , 2008, Acta Neuropathologica.

[25]  A. Lees,et al.  Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. , 2005, Brain : a journal of neurology.

[26]  Nick C Fox,et al.  Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy , 2005, Neurology.

[27]  A. Singleton,et al.  The tau H2 haplotype is almost exclusively Caucasian in origin , 2004, Neuroscience Letters.

[28]  Niall P Quinn,et al.  The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. , 2004, Brain : a journal of neurology.

[29]  D. Dickson,et al.  Inferior olivary hypertrophy is uncommon in progressive supranuclear palsy , 2004, Acta Neuropathologica.

[30]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[31]  D. Dickson,et al.  Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain Bank , 2003, Movement disorders : official journal of the Movement Disorder Society.

[32]  D W Dickson,et al.  Atrophy of superior cerebellar peduncle in progressive supranuclear palsy , 2003, Neurology.

[33]  C. Robinson,et al.  Progressive supranuclear palsy diagnosis and confounding features: Report on 16 autopsied cases , 2002, Movement disorders : official journal of the Movement Disorder Society.

[34]  H. Braak,et al.  Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.

[35]  A. Kakita,et al.  Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration , 2002, Acta Neuropathologica.

[36]  N. Quinn,et al.  Multiple system atrophy: A review of 203 pathologically proven cases , 1997, Movement disorders : official journal of the Movement Disorder Society.

[37]  M. Hallett,et al.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[38]  I Litvan,et al.  Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[39]  K. Abe,et al.  [A 71-year-old woman with progressive gait disturbance and dementia]. , 1995, No to shinkei = Brain and nerve.

[40]  D. Maraganore,et al.  Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. , 1995, Journal of neurology, neurosurgery, and psychiatry.